Summary
Cannot verify label alignment because the provided FDA excerpt support in the prompt is not actually evaluated against an AI-generated response; moreover, the prompt content includes an internal label-evidence check that is unverifiable and not tied to a specific AI response to audit.
Category Scores
Accurate Statements
The warning about increased risk of thrombotic events after premature discontinuation is described in the provided label excerpts (Section 5.1).
Supported by provided excerpt summary for Section 5.1 (premature discontinuation increases risk of thrombotic events; increased stroke observed during transition from ELIQUIS to warfarin).
The warning about spinal/epidural anesthesia or puncture and risk of epidural/spinal hematoma is described in the provided label excerpts (Section 5.3).
Supported by provided excerpt text for Section 5.3 (risk of epidural/spinal hematoma; timing and monitoring language).
Unsupported Statements
Claims that can only be validated via specific FDA text/citations but are not verifiably tied to any auditable AI-generated response content in the prompt (e.g., detailed assertions about transition-to-warfarin stroke rate, and conversion timing to other anticoagulants).
No actual AI-generated response text was provided to audit; the prompt includes an 'evidence summary' that itself is not verifiable as an audit of a specific AI response.
Contradictions
Important Omissions
No auditable AI response content was supplied to evaluate across FDA label elements (contraindications, boxed warnings, full dosing/administration instructions, adverse reactions, etc.).
Importance:
High
Safety Assessment
Potential Patient Risk:
Moderate
Because the audit cannot confirm alignment to an actual AI-generated response, potential risk is elevated due to inability to verify what claims were made or whether important label elements were omitted.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Verifiable
Primary Issue
No AI-generated prescribing-information response was provided to evaluate; therefore alignment cannot be assessed, and any 'supported/unsupported' determinations are unverifiable.
Suggested Improvement
Provide the exact AI-generated response text to audit, then re-run evaluation against the supplied FDA label excerpts (and include contraindications/boxed warnings/dosing details if the AI mentioned them).